Free shipping on all orders over $ 500

ITK antagonist 

Cat. No. M27849

All AbMole products are for research use only, cannot be used for human consumption.

ITK antagonist  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

ITK antagonist (compound 10 n) is a potent, orally active and selective ITK (Interleukin-2 inducible T-cell kinase) antagonist (IC50=1 and 20 nM in different assays). ITK antagonist inhibits insulin receptor kinase (IRK) with an IC50 of 160 nM.

Chemical Information
Molecular Weight 494.65
Formula C26H34N6O2S
CAS Number 1149753-56-9
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Kristina Lechner, et al. Gastroenterology. Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative Colitis

[2] Andrew Lipsky, et al. Hematology Am Soc Hematol Educ Program. Managing toxicities of Bruton tyrosine kinase inhibitors

[3] Vincent Sibaud, et al. Am J Clin Dermatol. Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors

[4] Hua Xu, et al. ACS Chem Biol. PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor

[5] Jingjing Wu, et al. J Hematol Oncol. Second-generation inhibitors of Bruton tyrosine kinase

Related Itk Products
Soquelitinib

Soquelitinib (CPI-818) is an orally active and highly selective covalent interleukin-2-inducible kinase (ITK) inhibitor. Soquelitinib is active in six different models of T cell-mediated inflammatory and immune disease. Soquelitinib increases tumor infiltration of normal CD8+ cells that possess enhanced T effector function.

ITK degrader 2

ITK degrader 2 is a modulator of targeted ubiquitination and a targeted protein degrading molecule.

ITK degrader 1

ITK degrader 1 is a highly selective degrader of interleukin-2-inducible T-cell kinase (ITK; DC50=3.6 nM in vivo in mice).

PRN694 

PRN694 is an irreversible, highly selective and potent covalent interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) dual inhibitor with IC50s of 0.3 nM and 1.4 nM, respectively. PRN694 exhibits extended target residence time on ITK and RLK, enabling durable attenuation of effector cells in vitro and in vivo.

GNE-9822 

GNE-9822 is a potent, orally active and selective ITK inhibitor with a Ki value of 0.7 nM. GNE-9822 has good ADME properties. GNE-9822 can be used in research of asthma.

  Catalog
Abmole Inhibitor Catalog




Keywords: ITK antagonist  supplier, Itk, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.